[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346331-105":59,"doc-detail-346331-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","optimizing-radiotherapy-for-early-stage-breast-cancer-a-comparative-seer-based-analysis-of-neoadjuvant-intraoperative-and-postoperative-approaches","Optimizing radiotherapy for early-stage breast cancer: A comparative SEER-based analysis of neoadjuvant, intraoperative, and postoperative approaches","","Objective: Compare long-term survival in early-stage breast cancer patients receiving different radiation therapy modalities. Methods: Retrospective SEER data were used to compare overall survival (OS), breast cancer-specific survival (BCSS), and second primary malignancies (SPM) between postoperative radiotherapy (PORT), neoadjuvant radiotherapy (NART), and intraoperative radiotherapy (IORT) after 1:1 propensity score matching. Results: Among 457,166 patients, matched NART showed worse 20-year OS, with no BCSS advantage; SPM risk differed across groups. Conclusion: Compared with PORT, NART and IORT did not yield survival advantages; sequencing requires careful evaluation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/optimizing-radiotherapy-for-early-stage-breast-cancer-a-comparative-seer-based-analysis-of-neoadjuvant-intraoperative-and-postoperative-approaches/346331/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/optimizing-radiotherapy-for-early-stage-breast-cancer-a-comparative-seer-based-analysis-of-neoadjuvant-intraoperative-and-postoperative-approaches/346331.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study objective in early-stage breast cancer radiotherapy?","Question",{"text":112,"@type":113},"To compare long-term survival outcomes among patients treated with postoperative radiotherapy (PORT), neoadjuvant radiotherapy (NART), and intraoperative radiotherapy (IORT).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the study conducted and how were groups balanced?",{"text":117,"@type":113},"The analysis used retrospective SEER database data and compared outcomes after 1:1 propensity score matching. Outcomes included OS, BCSS, and second primary malignancies (SPM).",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show regarding 20-year overall survival and breast cancer-specific survival?",{"text":121,"@type":113},"After matching, the 20-year OS for NART was lower than for PORT, while no significant difference in BCSS was observed between NART and PORT. Additionally, NART showed a different SPM risk profile versus PORT.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346331,1790117098,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Original research article SCIENCE PROGRESS  \nOptimizing radiotherapy for early-stage breast cancer: A comparative SEER-based analysis of neoadjuvant, intraoperative, and postoperative approaches  \nScience Progress 2026, Vol. 109(1) 1–15 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/00368504261420988](DOI: 10.1177/00368504261420988)[ ](DOI: 10.1177/00368504261420988)[journals.sagepub.com/home/sci](journals.sagepub.com/home/sci)  \nLingrui Li 1,\\#, Xiangyi Kong 1,\\#, Zhuang Xiong2,\\#, Xiangyu Wang 1,\\#, Wenxiang Zhang 1, Yi Fang 1, Zhongzhao Wang 1 and Jing Wang 1   \nAbstract  \nObjective: To compare long-term survival in early-stage breast cancer patients treated with different radiation therapy modalities.  \nMethods: Data was retrospectively derived from SEER database. We compared overall survival (OS), breast cancer speciﬁc survival (BCSS) and second primary malignancies (SPM) in early-stage breast cancer patients treated with postoperative radiotherapy (PORT) versus those treated neoadjuvant radiotherapy (NART) and intraoperative radiotherapy (IORT) after propensity score matching by 1:1 .  \nResults: A total of 457,166 patients were included in this study. After matching, the 20-year OS of 1441 patients in NART cohort was lower than that in PORT cohort  \n1 Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China  \n2Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China  \n\\#These authors contributed equally to this article  \nCorresponding author:  \nYi Fang, Zhongzhao Wang, Jing Wang, Department of Breast Surgery, China National Cancer Center/Cancer Hospital, No.17, Panjiayuan Nanli, Chaoyang District, Beijing, PR China.  \nEmail: [fangyi@cicams.ac.cn](fangyi@cicams.ac.cn), [wangzhongzhao206@sina.com](wangzhongzhao206@sina.com), [wangjing@cicams.ac.cn](wangjing@cicams.ac.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms  \nof the Creative Commons Attribution-NonCommercial 4.0 License ([https://](https://)[ ](https://)[creativecommons.org/l](creativecommons.org/l)icenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as speciﬁed on the SAGE and Open Access page ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.com/en-us/nam/open-access-at-sage)).  \n(p\u003C0.01), particularly in hormone receptor positive patients (p\u003C0.01). NART were dependent prognostic factors for 20-year OS [Hazard Ratio (HR):1.21, 95%CI: 1.06– 1.38, p\u003C0.01). No signiﬁcant difference in BCSS was observed between NART and PORT treatments. Additionally, patients undergoing NART had a lower risk of all SPM (p = 0.01) and second solid cancers (p = 0.02) but a comparable risk of second hematological malignancies (p = 0.55) than patients administered PORT. HR-positive was a risk factor for SPM. No OS, BCSS or SPM risk difference were signiﬁcantly observed in the 2096 pairs of IORT and PORT groups.  \nConclusion: Compared to PORT, NART and IORT don’t offer survival advantages for early-stage breast cancer patients. Altering the sequence of radiotherapy requires careful evaluation.  \nKeywords  \nNeoadjuvant radiotherapy, intraoperative radiotherapy, survival, breast-conserving surgery, second primary malignancies  \nIntroduction  \nGlobally, breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related death in women. 1,2 The reduction in breast cancer mortality has been achieved through a multidisciplinary approach involving surgical oncology, radiation oncology, and medical oncology.3 Following breast-conserving surgery (BCS), adjuvant radiotherapy (RT) after surger","cbCaihvXkOTgFrAA","https://ap.wps.com/l/cbCaihvXkOTgFrAA","pdf",719597,15,"English","# Abstract\n# Objective\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the study objective in early-stage breast cancer radiotherapy?\",\"answer\":\"To compare long-term survival outcomes among patients treated with postoperative radiotherapy (PORT), neoadjuvant radiotherapy (NART), and intraoperative radiotherapy (IORT).\"},{\"question\":\"How was the study conducted and how were groups balanced?\",\"answer\":\"The analysis used retrospective SEER database data and compared outcomes after 1:1 propensity score matching. Outcomes included OS, BCSS, and second primary malignancies (SPM).\"},{\"question\":\"What did the results show regarding 20-year overall survival and breast cancer-specific survival?\",\"answer\":\"After matching, the 20-year OS for NART was lower than for PORT, while no significant difference in BCSS was observed between NART and PORT. Additionally, NART showed a different SPM risk profile versus PORT.\"}]","Optimizing radiotherapy for early-stage breast cancer: A comparative SEER-based analysis of neoadjuvant, intraoperative, and postoperative approaches | PDF",1790060948,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27ef75c81ab6f0dec13ac6fbb7c5b07d.webp",983,1415,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb0f4adbd8020b04685d142a315d2d17.webp",982,1414,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5d4179aad895f0c997dc15f36984180.webp",981,1412,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55d3ec4c0b9f284e4b3f2ca5054f941a.webp",980,1411]